Christina (Tina) P./LinkedIn
Jun 21, 2026, 14:38
Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Bleeding Risks and Blood Thinners: APS Awareness Day 21
Blood thinners (also called anticoagulants) are medicines that prevent blood clots.
They’re often used in conditions like Antiphospholipid Syndrome (APS) to reduce the risk of strokes, deep vein thrombosis (DVT), and other clot-related issues.
Blood thinners save lives by preventing dangerous clots — but they must be taken carefully to avoid serious bleeding.
Knowing the risks helps you stay safe and prepared.”
Stay updated with Hemostasis Today.
-
Jun 21, 2026, 14:32Moeen Hoseini: The Sex-Specific Associations Between Inflammatory Biomarkers and Vascular Events
-
Jun 21, 2026, 14:23Orton Lungu: Navigating High-Risk Pregnancy in Women Living With Sickle Cell Disease
-
Jun 21, 2026, 14:11Alexandre Kauskot: A Guide to Paris’s Best Riverside Spots for ISTH 2026 Attendees
-
Jun 21, 2026, 14:10Avidesh Panday: Data-Driven Stroke Care Transformation at EWMSC
-
Jun 21, 2026, 13:41Emmanuel J. Favaloro: Honored to Receive the ISLH Wallace H. Coulter Distinguished Lecture Award
-
Jun 21, 2026, 11:50Khalil Ahmad: The Incredible Journey of a Red Blood Cell – A Lifelong Mission of Oxygen Delivery
-
Jun 21, 2026, 08:44Patient Experience Sheds Light on Complexities of Antithrombotic Care in APS – APS Foundation of America
-
Jun 21, 2026, 08:04Phil Ambery: Next-Generation Endothelin Therapeutics Renew Interest in a Proven Pathway
-
Jun 21, 2026, 07:50Pallavi Madhiraju: Evategrel Shows Promise for Rapid and Consistent Platelet Inhibition